XML 50 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
REVENUE REVENUE (Tables)
 12 Months Ended
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]

The following table summarizes the disaggregation of revenue by nature:
 
Year Ended December 31,
Dollars in Millions
2019
 
2018
 
2017
Net product sales
$
25,174

 
$
21,581

 
$
19,258

Alliance revenues
597

 
647

 
962

Other revenues
374

 
333

 
556

Total Revenues
$
26,145

 
$
22,561

 
$
20,776
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
 
Year Ended December 31,
 
2019
 
2018
 
2017
McKesson Corporation
26
%
 
25
%
 
24
%
AmerisourceBergen Corporation
20
%
 
20
%
 
18
%
Cardinal Health, Inc.
17
%
 
17
%
 
15
%
Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]
The following table summarizes GTN adjustments:
 
Year Ended December 31,
Dollars in Millions
2019
 
2018
 
2017
Gross product sales
$
37,206

 
$
30,174

 
$
25,499

GTN adjustments(a)
 
 
 
 
 
Charge-backs and cash discounts
(3,675
)
 
(2,735
)
 
(2,084
)
Medicaid and Medicare rebates
(4,941
)
 
(3,225
)
 
(2,086
)
Other rebates, returns, discounts and adjustments
(3,416
)
 
(2,633
)
 
(2,071
)
Total GTN adjustments
(12,032
)
 
(8,593
)
 
(6,241
)
Net product sales
$
25,174

 
$
21,581

 
$
19,258

(a)
Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $132 million, $96 million and $71 million for the years ended December 31, 2019, 2018 and 2017, respectively.
Revenue from External Customers by Products and Services [Table Text Block]
The following table summarizes the disaggregation of revenue by product and region:
 
Year Ended December 31,
Dollars in Millions
2019
 
2018
 
2017
Prioritized Brands
 
 
 
 
 
Revlimid
$
1,299

 
$
—

 
$
—

Eliquis
7,929

 
6,438

 
4,872

Opdivo
7,204

 
6,735

 
4,948

Orencia
2,977

 
2,710

 
2,479

Pomalyst/Imnovid
322

 
—

 
—

Sprycel
2,110

 
2,000

 
2,005

Yervoy
1,489

 
1,330

 
1,244

Abraxane
166

 
—

 
—

Empliciti
357

 
247

 
231

Inrebic
5

 
—

 
—

 
 
 
 
 
 
Established Brands
 
 
 
 
 
Baraclude
555

 
744

 
1,052

Vidaza
58

 
—

 
—

Other Brands(a)
1,674

 
2,357

 
3,945

Total Revenues
$
26,145

 
$
22,561

 
$
20,776

 
 
 
 
 
 
United States
$
15,342

 
$
12,586

 
$
11,358

Europe
6,266

 
5,658

 
4,988

Rest of World
4,013

 
3,733

 
3,877

Other(b)
524

 
584

 
553

Total Revenues
$
26,145

 
$
22,561

 
$
20,776


(a)
Includes BMS and Celgene products in 2019.
(b)
Other revenues include royalties and alliance-related revenues for products not so